search
Back to results

Stroke Home Rehabilitation With WeReha (WR)

Primary Purpose

Stroke, Acute, Stroke

Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
WeReha
Sponsored by
CoRehab s.r.l.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke, Acute focused on measuring home rehabilitation, technology, stroke, biofeedback, games

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Ages Eligible for Study: Over the age of 18
  • Sexes Eligible for Study: All
  • First-time ischemic or haemorrhagic stroke, as documented by a CT or MRI
  • Patients able to sit for at least ten minutes and to look after own affairs without assistance i.e. a Modified Rankin Scale (MRS)≤ 2
  • Montreal Cognitive Assessment (MoCA) ≥12
  • Ability and willingness to participate in the study
  • Signed consent form

Exclusion Criteria:

  • Significant medical conditions that affected function prior to the stroke and would limit normal stroke rehabilitation (e.g. musculoskeletal condition affecting arm function or cardiac condition limiting basic activities of daily living).
  • Bilateral weakness of upper extremities
  • Unavailability of a caregiver
  • Participation in another clinical trial involving rehabilitation (recreational therapy, occupational therapy, physiotherapy) or an investigational drug.

Sites / Locations

  • D'Annunzio University of Chieti-Pescara
  • Royal Victoria Hospital
  • Ulster Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients with stroke

Arm Description

Rehabilitation of patients with stroke using a new technological device: WeReha

Outcomes

Primary Outcome Measures

Total number of patients enrolled
A patient is considered enrolled in the study if they are within the inclusion criteria and voluntarily accept to participate and sign the consent form
Total number of active patients
A patient that has used the device for at least 4 "active weeks". An "active week" is a week in which the patient has performed at least three sessions with WeReha for a minimum of 15 minutes each
Total number of patients who drop off
Average number of active weeks for each patient
: the average number of active weeks is evaluated as the total number of active weeks divided by the number of patients enrolled
Activity participation
Average of minutes per day dedicated to exercises with WeReha
Questionnaire: Technology Acceptance Model (TAM)
The Technology Acceptance Model is a questionnaire that evaluate the acceptance of the rehabilitation platform WeReha by the patients. The TAM questionnaire comprises 22 items (divided into 4 area) each rated in a 7-point Likert-scale, whereby a score of 1 refers to "I do not agree at all" and a score of 7 refers to "I agree entirely". The 4 area are: Perceived Ease of Use (maximal score 49, minimum score 7) Perceived Usefulness (maximal score 42, minimum score 6) Attitude Toward Using (maximal score 35, minimum score 5) Behavioral Intention to Use (maximal score 28, minimum score 4). The scores achived in the different area are summed to have a total score.The total maximum score, corresponding to 154, indicates a complete acceptance of the use of a technology device, such as WeReha, for the rehabilitation process; the minimum score, corresponding to 22, indicates a tendency to refuse technology for the rehabilitation process.

Secondary Outcome Measures

Barthel index
Disability Scale: Modified Rankin Score (mRS)
The Modified Rankin Score (mRS) is a 6 point disability scale with possible scores ranging from 0 to 5. A separate category of 6 is usually added for patients who expire. The Modified Rankin Score (mRS) is the most widely used outcome measure in stroke clinical trials
Training time
Time dedicated by the specialised personnel to each patient for training to learn the WeReha device before leaving the trial site
Number of calls
Number of calls per week for clinical and technical assistance specific for the WeReha device, registered on a paper or software spreadsheet by the sponsor

Full Information

First Posted
February 21, 2019
Last Updated
June 14, 2019
Sponsor
CoRehab s.r.l.
Collaborators
Engineering Ingegneria Informatica SpA, Fondazione Bruno Kessler
search

1. Study Identification

Unique Protocol Identification Number
NCT03964662
Brief Title
Stroke Home Rehabilitation With WeReha
Acronym
WR
Official Title
A New Solution for Home Rehabilitation of Stroke Patients: WeReha
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 18, 2018 (Actual)
Primary Completion Date
February 28, 2020 (Anticipated)
Study Completion Date
February 28, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
CoRehab s.r.l.
Collaborators
Engineering Ingegneria Informatica SpA, Fondazione Bruno Kessler

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
WeReha is an innovative device for the home rehabilitation of stroke patients developed within the scope of the EU funded project MAGIC-PCP [5]. WeReha is a system that allows patients to perform exercises in a home environment with remote supervision integrated within regular rehabilitation. The principle on which the product is based is that of biofeedback guided rehabilitation, designed to stimulate muscle recovery and contribute to a more effective and more motivating rehabilitation of neuro-motor patterns. WeReha is completely adaptable, allowing only authorized to assign exercises, by planning specific sequences of movements. WeReha product is composed by the following elements: a tablet with a proprietary application on it (the "WeReha app") an inertial sensor with accelerometers, gyroscopes and magnetometers (the "sensor") elastic straps allowing the user to wear it on different parts of the body (the "straps") a series of 3D printed objects where the sensor can be placed that become animated (the "smart objects") a web portal for clinical staff through which they can manage and monitor users (the "web-application") The WeReha app presents the patient with a series of rehabilitation exercises in the form of a number of interactive games, driven by body movement, which is captured by the sensor or the hand specific movements using the smart objects. A session with WeReha always starts with a questionnaire on the system, through which the software gains an understanding of the patient's health conditions and the presence or not of a caregiver for the session. Based on this questionnaire, the software adapts the daily session to minimise risks while maintaining a high level of rehabilitation to help the patient reach their goals. The device works with and without an internet connection, but when the device is connected to the internet, supervisors are able to provide supervision and remote support through a web application. The web application is hosted on a dedicated server located inside the hospital. Only trained staff will be provided with access to the web application with a unique username and password required for sign on. The exercises assigned for the client to perform at home, are at the discretion of the clinician who is caring for the patient and might require the presence of a caregiver. The goal of this study is to investigate the applicability and utility of an innovative technology product such as WeReha to the home rehabilitation of stroke patients as an integrative solution to a conventional exercise program and to assess its acceptance by the patient, caregivers and clinic professionals. Patients will use WeReha for their home rehabilitation in addition to traditional treatments for up to 12 weeks. The Inclusion criteria for the study have been kept broad in order to assess these factors on a large enough scale, so as not to limit the usage of the device to a specific sub-group of patients. If patients enrolled are in a subacute phase (i.e. within the first 6 months after the stroke onset), they will be enrolled before leaving the hospital or the rehabilitation department and reaching their home. If patients are considered to be in their chronic phase (i.e. over 6 months after stroke onset), they will be enrolled during an outpatient treatment or on a volunteer basis. Before starting the trial with WeReha, every patient enrolled will receive proper training from a person dedicated to the project (who will be referred to as the "dedicated figure") appointed by the hospital and financially supported by the sponsor of the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Acute, Stroke
Keywords
home rehabilitation, technology, stroke, biofeedback, games

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The goal of this study is to assess the acceptance and validity of a new technology such as WeReha for home rehabilitation of patients following a stroke episode either in sub-acute or chronic phase. The investigation will be conducted in two different countries: two sites in Northern Ireland and one in Italy.
Masking
None (Open Label)
Allocation
N/A
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients with stroke
Arm Type
Experimental
Arm Description
Rehabilitation of patients with stroke using a new technological device: WeReha
Intervention Type
Device
Intervention Name(s)
WeReha
Intervention Description
Rehabilitation of stroke patients with the device WeReha
Primary Outcome Measure Information:
Title
Total number of patients enrolled
Description
A patient is considered enrolled in the study if they are within the inclusion criteria and voluntarily accept to participate and sign the consent form
Time Frame
Through study completion, an average of 1 year
Title
Total number of active patients
Description
A patient that has used the device for at least 4 "active weeks". An "active week" is a week in which the patient has performed at least three sessions with WeReha for a minimum of 15 minutes each
Time Frame
Through study completion, an average of 1 year
Title
Total number of patients who drop off
Time Frame
Through study completion, an average of 1 year
Title
Average number of active weeks for each patient
Description
: the average number of active weeks is evaluated as the total number of active weeks divided by the number of patients enrolled
Time Frame
Through study completion, an average of 1 year
Title
Activity participation
Description
Average of minutes per day dedicated to exercises with WeReha
Time Frame
Through study completion, an average of 1 year
Title
Questionnaire: Technology Acceptance Model (TAM)
Description
The Technology Acceptance Model is a questionnaire that evaluate the acceptance of the rehabilitation platform WeReha by the patients. The TAM questionnaire comprises 22 items (divided into 4 area) each rated in a 7-point Likert-scale, whereby a score of 1 refers to "I do not agree at all" and a score of 7 refers to "I agree entirely". The 4 area are: Perceived Ease of Use (maximal score 49, minimum score 7) Perceived Usefulness (maximal score 42, minimum score 6) Attitude Toward Using (maximal score 35, minimum score 5) Behavioral Intention to Use (maximal score 28, minimum score 4). The scores achived in the different area are summed to have a total score.The total maximum score, corresponding to 154, indicates a complete acceptance of the use of a technology device, such as WeReha, for the rehabilitation process; the minimum score, corresponding to 22, indicates a tendency to refuse technology for the rehabilitation process.
Time Frame
Through treatment completion, an average of 3 months
Secondary Outcome Measure Information:
Title
Barthel index
Time Frame
At the beginning of the treatment (baseline) and through treatment completion, an average of 3 months
Title
Disability Scale: Modified Rankin Score (mRS)
Description
The Modified Rankin Score (mRS) is a 6 point disability scale with possible scores ranging from 0 to 5. A separate category of 6 is usually added for patients who expire. The Modified Rankin Score (mRS) is the most widely used outcome measure in stroke clinical trials
Time Frame
At the beginning of the treatment (baseline) and through treatment completion, an average of 3 months
Title
Training time
Description
Time dedicated by the specialised personnel to each patient for training to learn the WeReha device before leaving the trial site
Time Frame
Through study completion, an average of 1 year
Title
Number of calls
Description
Number of calls per week for clinical and technical assistance specific for the WeReha device, registered on a paper or software spreadsheet by the sponsor
Time Frame
Through study completion, an average of 1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Ages Eligible for Study: Over the age of 18 Sexes Eligible for Study: All First-time ischemic or haemorrhagic stroke, as documented by a CT or MRI Patients able to sit for at least ten minutes and to look after own affairs without assistance i.e. a Modified Rankin Scale (MRS)≤ 2 Montreal Cognitive Assessment (MoCA) ≥12 Ability and willingness to participate in the study Signed consent form Exclusion Criteria: Significant medical conditions that affected function prior to the stroke and would limit normal stroke rehabilitation (e.g. musculoskeletal condition affecting arm function or cardiac condition limiting basic activities of daily living). Bilateral weakness of upper extremities Unavailability of a caregiver Participation in another clinical trial involving rehabilitation (recreational therapy, occupational therapy, physiotherapy) or an investigational drug.
Facility Information:
Facility Name
D'Annunzio University of Chieti-Pescara
City
Chieti
Country
Italy
Facility Name
Royal Victoria Hospital
City
Belfast
ZIP/Postal Code
BT12 6BA
Country
United Kingdom
Facility Name
Ulster Hospital
City
Belfast
ZIP/Postal Code
BT16 1RH
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
33402861
Citation
Bellomo RG, Paolucci T, Saggino A, Pezzi L, Bramanti A, Cimino V, Tommasi M, Saggini R. The WeReha Project for an Innovative Home-Based Exercise Training in Chronic Stroke Patients: A Clinical Study. J Cent Nerv Syst Dis. 2020 Dec 13;12:1179573520979866. doi: 10.1177/1179573520979866. eCollection 2020.
Results Reference
derived

Learn more about this trial

Stroke Home Rehabilitation With WeReha

We'll reach out to this number within 24 hrs